S311
Clinical Applications of Recombinant Human Bone Morphogenetic Protein and In-Situ Tissue Engineering in Jaw Reconstruction
Clinical Applications of Recombinant Human Bone Morphogenetic Protein and In-Situ Tissue Engineering in Jaw Reconstruction
Friday, September 12, 2014
7:00 AM-8:30 AM
7:00 AM-8:30 AM
Location
317B (Hawaii Convention Center)
Speaker:
R. Gilbert Triplett DDS, PhD
Dallas, TX, USA
CDE/CME Offered: CDE/CME
Synopsis
Recombinant Human Bone Morphogenetic Protein (rhBMP-2) regenerates normal bone de-novo without the need and added morbidity of bone harvesting. Now ridge preservations, ridge augmentations, sinus lift surgeries, and even continuity defects can be reconstructed with such grafting using tissue engineering directly in the patient, a process referred to as in-situ tissue engineering.
Learning Objectives
- Discuss growth factors and bone regeneration through tissue engineering;
- Better utilize rhBMP-2 and the best surgical techniques to enhance their performance; and
- Achieve a quality and quantity of bone regenration for jaw reconstruction without using autogenous bone.
» Back to: Clinical Courses